Demographic and clinical profile of patients (N=29)
| Sex, n (%) | |
| Male | 19 (65.5) |
| Female | 10 (34.5) |
| Mean age (SD) in years | 43.9 (12.8) |
| Presence of decrease in vision, n (%) | |
| Yes | 21 (72.4) |
| No | 8 (27.6) |
| Median (IQR) duration of visual complaints in months (n=21) | 8 (3–12) |
| Symptom of field cut, n (%) | |
| Yes | 4 (13.8) |
| No | 25 (86.2) |
| Presence of diplopia, n (%) | |
| Yes | 4 (13.8) |
| No | 25 (86.2) |
| Mean tumour volume (±SE) in cubic centimetres | 11.7±0.2 |
| Mean logMAR VA in the right eye (SD) | 0.3(0.3) |
| Mean logMAR in the left eye (SD) | 0.4(0.4) |
| Visual field defects, n (%) | |
| No defect | 8 (27.6) |
| Bilateral superior temporal quadrantanopia | 3 (10.3) |
| Bitemporal hemianopia | 12 (41.4) |
| Advanced depression | 1 (3.4) |
| Others | 5 (17.2) |
| Mean follow-up duration (±SE) in months | 20.8±6.4 |
| Disc pallor (%), n=58 eyes | |
| No pallor | 26 (44.8) |
| Temporal pallor | 23 (39.7) |
| Optic atrophy | 9 (15.5) |
| Mean RNFL thickness in microns (SD), n=58 eyes | |
| Superior | 115.1 (32.4) |
| Nasal | 64.9 (22.6) |
| Inferior | 118.7 (33.5) |
| Temporal RNFL | 57.1 (20.6) |
logMAR, logarithmic minimum angle of resolution; RNFL, retinal nerve fibre layer; VA, visual acuity.